PLA2G1B Antikörper (Biotin)

Produktnummer ABIN568378

Produktdetails anti-PLA2G1B Antikörper (Biotin)

Target: PLA2G1B (Phospholipase A2, Group IB (PLA2G1B))

Reaktivität: Bee

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G1B Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunodiffusion (ID), Immunoprecipitation (IP), Dot Blot (DB), Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)

Spezifität: Phospholipase A2 from bee venom. The reagents were evaluated for potency, purity and specificity using most or all of the following techniques: Immunoelectrophoresis, Cross-Immunoelectrophoresis, Single Radial Immunodiffusion (Ouchterlony), Block Titration, ELISA, Immunoblotting and Enzyme Inhibition. Cross-reactivities against enzymes of other sources may occur but have not been determined.

Produktmerkmale: Molar Ratio: Biotin/IgG ~6.1

Aufreinigung: Ammonium Sulphate Precipitation and Ion Exchange Chromatography.

Immunogen: Phospholipase A2 isolated and purified from bee venom. Freund’s complete adjuvant is used in the first step of the immunization procedure.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Rekonstitution: Restore by adding 1 mL of sterile distilled water.

Konzentration: 10 mg/mL

Buffer: PBS, pH 7.2 without preservatives.

Konservierungsmittel: Without preservative

Handhabung: Avoid Repeated thawing and freezing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store lyophilized at 2-8 °C and reconstituted at 2-8 °C for one week or (in aliquots) at -20 °C for longer.

Details zu PLA2G1B

Target: PLA2G1B (Phospholipase A2, Group IB (PLA2G1B))

Andere Bezeichnung: Phospholipase A2 (PLA2G1B Produkte)

Synonyme: C133 antikoerper, CG4346 antikoerper, Dmel\\CG42237 antikoerper, Dmel_CG4346 antikoerper, PLA2 antikoerper, GB13351 antikoerper, bvPLA2 antikoerper, PLA2A antikoerper, PPLA2 antikoerper, sPLA(2)-IB antikoerper, Pla2a antikoerper, sPLA2IB antikoerper, PLA2G1B antikoerper, CG42237 gene product from transcript CG42237-RB antikoerper, phospholipase A2 antikoerper, phospholipase A2 group IB antikoerper, phospholipase A2, group IB, pancreas antikoerper, phospholipase A2 group IVA antikoerper, CG42237 antikoerper, PLA2 antikoerper, LOC100631065 antikoerper, Pla2 antikoerper, PLA2G1B antikoerper, Pla2g1b antikoerper, PLA2G4A antikoerper

Hintergrund: Phospholipase A2 catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid, a precursor of eicosanoids including prostaglandins and leukotrienes. This enzyme has been proposed to hydrolyze phosphatidylcholine in lipoproteins to liberate lyso-PC and free fatty acids in the arterial wall, thereby facilitating the accumulation of bioactive lipids and modified lipoproteins in atherosclerotic foci. Phospholipase A2 IIA can exert beneficial action in the context of infectious diseases since recent studies have shown that this enzyme exhibits potent bactericidal effects. Induction of the synthesis of Phospholipase A2 IIA is generally initiated by endotoxin and a limited number of cytokines via paracrine and/or autocrine processes.Synonyms: Allergen Api m I, Phosphatidylcholine 2-acylhydrolase

Gen-ID: 406141

NCBI Accession: NP_001011614

UniProt: P00630

Pathways: Inositol Metabolic Process, VEGF Signaling